Currently, unenhanced multi-detector computed tomography (MDCT) is considered the gold standard for detecting kidney stones, however the modality also delivers the highest radiation dose among imaging methods.

Clinicians may be able to use circulating tumor cells (CTCs) to develop a staging system that helps the treatment of metastatic breast cancer (MBC), according to research to be presented at the American Society of Clinical Oncology (ASCO) annual meeting June 1-5 in Chicago.

“Basically, anybody who knows anything about healthcare is opposed to these proposals,” said Sandy Praeger, a former president of the National Association of Insurance Commissioners.

Human growth hormone showed the potential to improve the memory and cognitive function of mice post-stroke, raising the possibility of a similar treatment for humans.

Konica Minolta Healthcare Americas is introducing a new worklist feature, Turn-Around-Time (TAT), for its Exa platform at the SIIM 2018 Annual Meeting May 31-June 2 in National Harbor, Maryland.

Hypertensive patients collect $1,920 more in annual healthcare expenditures compared to healthy individuals, according to a study published in the Journal of the American Heart Association on May 30.

Novel technology known as phase-base amplified MRI is the first to capture the brain’s movement in conjunction with a heartbeat, opening the door for earlier detection of brain disorders and abnormalities, researchers from Stanford University and the University of Auckland announced this week.

Eyes are, as the saying goes, a gateway to the soul—but recent research shows they may be key in improving diagnosis of and treatment of schizophrenia. RETeval, a handheld device used by optometrists to track electrical activity from the retina, may help detect abnormalities related to schizophrenia.

New guidelines from the American Cancer Society suggest beginning colorectal cancer (CRC) screening at age 45, instead of the current recommendation starting at age 50.

Athenahealth CEO Jonathan Bush issued an apology for “regrettable incidents” after it was reported he had admitted to assaulting his now former wife, but he’ll remain CEO of the health IT company as its under pressure to accept a takeover bid from activist hedge fund manager Paul Singer.